INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 414m ago
HOUSE PTR14m ago
SEC 13F14m ago
ROBINHOOD CHAIN14m ago
Public company

STIMNeuronetics, Inc.

CIK 0001227636

EDGAR filingsOpen in network
Disclosed transactions3
Buys / sells0 / 0
Max Insider Score21
Connections5with evidence

STIM · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
21
AA
Amin AvinashDirector
STIMNeuronetics, Inc.
Grant or award
A—
30.0K sh
May 28, 2026May 29, 2026
traded May 28, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 3841 · Surgical & Medical Instruments & Apparatus · Nov 4, 2026
  • ← Lobbied forevidence
    CHECKMATE GOVERNMENT RELATIONSLDA Q2Y 2026 second quarter · issues not listed · Aug 26, 2026
  • ← Insider ofevidence
    Amin AvinashDirector · May 29, 2026
  • ← Insider ofevidence
    Cucuz SashaDirector · May 29, 2026
  • ← Insider ofevidence
9
CS
Cucuz SashaDirector
STIMNeuronetics, Inc.
Grant or award
A
—
30.0K sh
May 28, 2026
May 29, 2026
traded May 28, 2026
+1d
SEC FORM 4

Evidence

17
RM
Rosengarten MeganDirector
STIMNeuronetics, Inc.
Grant or award
A—
30.0K sh
May 28, 2026May 29, 2026
traded May 28, 2026
+1dSEC FORM 4

Evidence

Rosengarten Megan
Director · May 29, 2026

Lobbying

$0 reported · de-duplicated
2026 Q2 $0 via firms2026 Q1 $0 via firms
  • CHECKMATE GOVERNMENT RELATIONS—2026 Q1 · posted Aug 26, 2026 ·
  • CHECKMATE GOVERNMENT RELATIONS—2026 Q2 · posted Aug 26, 2026 ·

Connected PAC contributions

FEC · direct to members

No contributions from a PAC connected to this company.